Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pablo Cagnoni Insider Profile
4 Followers
Pablo Cagnoni, EVP, Global R&D and Tech Ops at Onyx Pharma, holds 0.00 shares in Onyx Pharma (Ticker: ONXX), holds 221.17K shares in Incyte (Ticker: INCY), holds 66.08K shares in Rubius Therapeutics (Ticker: RUBY). Most recently, Pablo Cagnoni ― shares of Onyx Pharma on ― for an estimated value of ―.
Pablo Cagnoni Onyx Pharma (ONXX)EVP, Global R&D and Tech Ops
Onyx Pharma (ONXX)
EVP, Global R&D and Tech Ops
Not Ranked
Pablo Cagnoni has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Pablo Cagnoni holds in companies
Most Profitable Insider Trade
Stock:
Rubius Therapeutics
(RUBY)
(RUBY)
Rating:Informative Buy
Date:Apr 15, 2020 - Apr 15, 2021
Return:+436.80%
The most profitable trade made by Pablo Cagnoni
Pablo Cagnoni's Trading History
Onyx Pharma
―
―
―
―
Crispr Therapeutics AG
Nov 21, 2019
Director
Uninformative Buy
41.92K
$0.00
Rubius Therapeutics
Feb 01, 2023
―
Uninformative Sell
2.11K
$3.77K
Fusion Pharmaceuticals
―
―
―
―
Incyte
Jul 17, 2024
President, R&D
Uninformative Buy
―
$14.42M
List of latest transactions for each holding click on a transaction to see Pablo Cagnoni's performance on stock
You May Also Like
Pablo Cagnoni insider profile FAQ
What is the percentage of profitable transactions made by Pablo Cagnoni?
The percentage of profitable transactions made by Pablo Cagnoni is ―.
What is the average return per transaction made by Pablo Cagnoni?
The average return per transaction made by Pablo Cagnoni is ―.
What stocks does Pablo Cagnoni hold?
Pablo Cagnoni holds: ONXX, CRSP, RUBY, FUSN, INCY stocks.
What was Pablo Cagnoni’s latest transaction?
Pablo Cagnoni latest transaction was an Uninformative Buy of ―.
What was Pablo Cagnoni's most profitable transaction?
Pablo Cagnoni’s most profitable transaction was an Informative Buy of RUBY stock on April 15, 2020. The return on the trade was 436.80%.
What is Pablo Cagnoni's role in Onyx Pharma?
Pablo Cagnoni's role in Onyx Pharma is EVP, Global R&D and Tech Ops.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.